Written by Bente Prytz Mjølstad
(#3 of the Whole Person reflections series)
Have you ever thought about whether your regular GP knows more about you than your blood pressure or cholesterol levels? If so, might such knowledge be of any medical relevance?
Most of us visit our regular GP once or twice a year for more or less trivial complaints, and you are probably most interested in the GPs medical skills, and not so concerned about whether the doctor knows you as person or not. However, if you got seriously ill or had a chronic illness, would it still not matter? Continue reading “Does your regular GP know you – as a person? And if so, does it matter?”
Author Anna Luise Kirkengen
(#2 of the Whole Person reflections series)
What if one would weave a text by means of threads coloured by the recent topics of the on-going CauseHealth project. One thread would be causality, and how it is understood and applied in current biomedicine. Another would be ontology in the sense of how a human being and the human body is conceptualised in medicine and how this concept underpins the Western health care systems. A third thread would be methodology, and how the predominant methods for knowledge production, group based, randomised trials often including thousands of patients, might be radically challenged by the concept of N=1. A fourth thread would be stories in the sense of biographies before a person fell ill, and stories in the sense of testimonies of being ill – and how these have been systematically avoided as possible source of contamination in medical knowledge production. A fifth thread would then be knowledge condensates as these have grown both in number and normativity in the shape of clinical guidelines in all medical specialties during the latest years. Together, these threads can form quite different pictures, dependent on the frame applied. Continue reading “What if…”
In Bridging the Boundaries Between Scientists and Clinicians, Elena Rocca explores the field of drug risk assessment as an example of strict interdependence between basic biomedical research, clinical research, and clinical evaluation and shows how it would benefit from a closer collaboration between scientists and clinicians. Continue reading “New CauseHealth publication about risk assessment of drugs.”